Medical Action Industries Announces New Independent Director

Medical Action Industries Announces New Independent Director

BRENTWOOD, N.Y., May 22, 2013 (GLOBE NEWSWIRE) -- Medical Action Industries
Inc. (Nasdaq:MDCI) today announced that its Board of Directors has voted to
increase the size of the Board from six members to seven members and to
appoint Ms. Pamela R. Levy as an independent director. As an independent
director, she will also serve on the Board's Audit Committee.

Kenneth W. Davidson, Chairman of the Board, said, "We are very happy to have
Pam Levy join our board. Ms. Levy brings a wealth of experience in acquisition
financing, capital raising and debt agreement negotiation, enabling her to
provide critical insight into the capital markets and the assessment of our
strategic growth initiatives."

During the past twelve months, the Company has employed the services of two
companies for which Ms. Levy served as an executive or partner. These
companies and Ms. Levy provided advice to the Company regarding the
negotiation of its previous agreement in June 2012 and its new credit
agreement of May 17, 2013. After careful consideration of the facts of these
engagements and the NASDAQ rules related thereto, the Board determined that
Ms. Levy satisfies the definition of "independent director" set forth in
NASDAQ Stock Market Rule 5605(b)(1).

Ms. Pamela R. Levy currently serves as Founder, CEO and President of PEARL
Financial Advisors LLC, a healthcare debt capital advisory firm, a position
she has held since April 2013, and previously from March 2010 to October
2010.From November 2010 through March 2013, she was a Partner at White Oak
Merchant Partners, a debt capital advisory and merchant banking firm.From
1993 through February 2010, Ms. Levy served in multiple positions, including
as a senior officer and team leader, at Bank of America Merrill Lynch and
predecessors Banc of America Securities and NationsBank N.A.Her last position
was Managing Director, Head of Healthcare Leveraged Finance.In that role, she
led a team of professionals responsible for all aspects of debt capital
raising, including acquisition financing, recapitalizations, and leveraged
buyouts, for healthcare products and services, medical device, life science,
specialty pharmaceutical and other healthcare related corporate and private
equity clients.From 1984 to 1993, she was an officer at the Chase Manhattan
Bank, N.A.Ms. Levy currently serves on the Board of Directors and is Audit
Committee Chair of privately-held HCMC Legal, Inc., a provider of legal and
review management services, and human capital solutions to law firms, law
firms' clients, and large corporations.She received a B.A. degree in Middle
Eastern Studies at the University of California at Berkeley and her Masters of
International Affairs from Columbia University. She has earned both the CFA
(Chartered Financial Analyst) and CFP® (Certified Financial Planner®)

About Medical Action Industries Inc.

Medical Action is a diversified manufacturer and distributor of disposable
medical devices and a leader in many of the categories in which it
competes.Its products are marketed primarily to acute care facilities in
domestic and certain international markets.The Company has expanded its
target market to include physician, dental and veterinary offices, out-patient
surgery centers, long-term care facilities and laboratories.

Medical Action's products are marketed nationally by its direct sales
personnel and extensive network of healthcare distributors.The Company has
preferred vendor agreements with national and regional distributors, as well
as sole and multi-source agreements with group purchasing organizations.
Medical Action's common stock trades on the NASDAQ Global Select Market under
the symbol MDCI and is included in the Russell Microcap® Index.

CONTACT: John Sheffield - Executive Vice President
         and Chief Financial Officer
         (631) 231-4600

company logo
Press spacebar to pause and continue. Press esc to stop.